Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1016/j.ygyno.2020.04.703 http://scihub22266oqcxt.onion/10.1016/j.ygyno.2020.04.703 32370991!7188656!32370991     free     free     free Warning: file_get_contents(https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&id=32370991&cmd=llinks): Failed to open stream: HTTP request failed! HTTP/1.1 429 Too Many Requests in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 215 Deprecated: Implicit conversion from float 231.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 231.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 231.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Gynecol+Oncol 2020 ; 158 (1): 34-36 Nephropedia Template TP {{tp|p=32370991|t=2020. COVID-19 and ovarian cancer: Exploring alternatives to intravenous (IV) therapies |pdf=|usr=}}{{32370991}} gab.com Text COVID-19 and ovarian cancer: Exploring alternatives to intravenous (IV) therapies JO: Gynecol Oncol http://www.kidney.de/pget.php?&tw=1&pmid=32370991 #FOAvip * The pandemic COVID-19 requires alternative methods and thinking to keep healthcare professionals and patients safe. * In COVID-19 hot spots, oral therapies may be viable alternatives to intravenous therapies for treatment of ovarian cancer. * Minimizing patient visits to hospitals and cancer clinics may help mitigate the spread of SARS-CoV-2. Twit Text FOAVip COVID-19 and ovarian cancer: Exploring alternatives to intravenous (IV) therapies ????Gynecol Oncol http://www.kidney.de/pget.php?&tw=1&pmid=32370991 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=32370991 #FOAvip English Wikipedia <ref>{{Cite pmid|32370991}}</ref> COVID-19 and ovarian cancer: Exploring alternatives to intravenous (IV) therapies #MMPMID32370991 Monk BJ; Coleman RL; Moore KN; Herzog TJ; Secord AA; Matulonis UA; Slomovitz BM; Guntupalli SR; O'Malley DM Gynecol Oncol 2020[Jul]; 158 (1): 34-36 PMID32370991show ga * The pandemic COVID-19 requires alternative methods and thinking to keep healthcare professionals and patients safe. * In COVID-19 hot spots, oral therapies may be viable alternatives to intravenous therapies for treatment of ovarian cancer. * Minimizing patient visits to hospitals and cancer clinics may help mitigate the spread of SARS-CoV-2. |Administration, Oral[MESH] |Antineoplastic Combined Chemotherapy Protocols/*administration & dosage[MESH] |Betacoronavirus/isolation & purification[MESH] |COVID-19[MESH] |Coronavirus Infections/epidemiology/*prevention & control/virology[MESH] |Female[MESH] |Humans[MESH] |Infusions, Intravenous[MESH] |Organoplatinum Compounds/administration & dosage[MESH] |Ovarian Neoplasms/*drug therapy/*virology[MESH] |Pandemics/*prevention & control[MESH] |Pneumonia, Viral/epidemiology/*prevention & control/virology[MESH] |Poly(ADP-ribose) Polymerase Inhibitors/*administration & dosage[MESH]COVID-19 and ovarian cancer: Exploring alternatives to intravenous (IV(epmc).pdf DeepDyve Pubget Overpricing